🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the safety and tolerabil...
Status
Completed
Location
Stanford University Medical Center
Start Date
2015-06-08
Trial ID
NCT02466516
The primary objective of this study is to assess the safety and tolerabilit...
Status
Completed
Location
NIH Department of Laboratory Medicine
Start Date
2012-10-04
Trial ID
NCT01707472
Treatments Being Tested
The primary objective of this study is to evaluate whether SIM (formerly re...
Status
Terminated
Location
Mayo Clinic Hospital
Start Date
2012-12-05
Trial ID
NCT01672866
The primary objective of this study is to evaluate the safety and efficacy ...
Status
Terminated
Location
Mayo Clinic Hospital
Start Date
2012-10-29
Trial ID
NCT01672879
The purpose of this study is to evaluate whether simtuzumab (GS-6624) is ef...
Status
Completed
Location
Mayo Clinic Hospital
Start Date
2013-03-04
Trial ID
NCT01672853
Treatments Being Tested
The primary objective of this study is to evaluate the long term safety and...
Status
Terminated
Location
Arizona Pulmonary Specialists, Ltd.
Start Date
2012-10-18
Trial ID
NCT01759511
Treatments Being Tested
The primary objectives of this study are to determine the effect of simtuzu...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2013-01-31
Trial ID
NCT01769196
Treatments Being Tested
This study is to evaluate the efficacy and safety of simtuzumab (GS-6624) o...
Status
Completed
Location
Mayo Clinic
Start Date
2011-06-30
Trial ID
NCT01369498
Treatments Being Tested
This study will compare the efficacy of simtuzumab (GS-6624) versus placebo...
Status
Completed
Location
Birmingham Hematology and Oncology Associates, LLC
Start Date
2011-11
Trial ID
NCT01472198
Treatments Being Tested
The primary objective of this study is to compare the additive efficacy of ...
Status
Terminated
Location
Clearview Cancer Institute
Start Date
2011-12
Trial ID
NCT01479465
Treatments Being Tested